Abstract: Bacillus species are well known for their ability to control plant diseases through various mechanisms, including the production of secondary metabolites. Bacillus subtilis DFH08, an antagonist of Fusarium graminearum, and other Bacillus spp. that are antagonists of common fungal pathogens of canola were screened for peptide synthetase biosynthetic genes of fengycin and bacillomycin D. Specific polymerase chain reaction (PCR) primers identified B. subtilis strains DFH08 and 49 for the presence of the fenD gene of the fengycin operon. Bacillus cereus DFE4, Bacillus amyloliquefaciens strains DFE16 and BS6, and B. subtilis 49 were identified for the presence of the bamC gene of the bacillomycin D synthetase biosynthetic operon. Both fengycin and bacillomycin D were detected in the culture extract of strain Bs49, characterized through MALDI-TOF-MS (matrix-assisted laser desorption ionization -time of flight -mass spectrometry), and their antifungal activities demonstrated against F. graminearum and Sclerotinia sclerotiorum. This study designed and used specific PCR primers for the detection of potential fengycin-and bacillomycin D-producing bacterial antagonists and confirmed the molecular detection with the biochemical detection of the corresponding antibiotic produced. This is also the first report of a B. cereus strain (DFE4) to have bacillomycin D biosynthetic genes. Bacteria that synthesize these lipopeptides could act as natural genetic sources for genetic engineering of the peptide synthetases for production of novel peptides.
Introduction
Bacillus species produce a wide range of secondary metabolites that display a broad spectrum of activity and very diverse structures. These metabolites range from geneencoded antibiotics to a variety of small antibiotic peptides, which are synthesized nonribosomally (Moyne et al. 2004 ).
The lipopeptide antibiotics such as iturin, surfactin, fengycin, and plispastin fall under this category. The lipopeptides have a hydrophilic peptide portion and a hydrophobic fatty acid portion (Roongsawang et al. 2002) . Most of them are cyclic in nature, mediated by either b-hydroxy fatty acid (b-hydroxy type) or b-amino fatty acid (b-amino type). Bacillomycin D, which is a member of the iturin family along with mycosubtilin and iturin A, is made of one b-amino fatty acid and 7 a-amino acids. Fengycins are cyclic lipodecapeptides containing a b-hydroxy fatty acid with a side chain length of 16-19 carbon atoms. Four D-amino acids and ornithine (a nonproteinogenic residue) have been identified in the peptide portion of fengycin (Koumoutsi et al. 2004 ). The members of the iturin family exhibit strong antifungal and hemolytic activities and limited antibacterial activity (Maget-Dana and Peypoux 1994) . Fengycin shows specific antifungal activity against filamentous fungi and inhibits phospholipase A 2 (Nishikori et al. 1986 ). The nonribosomal synthesis of these lipopeptides is achieved through the involvement of large, modular, multienzyme templates designated peptide synthetases. Each module of the multimodular peptide synthetase is made up of approximately 1000 amino acids and catalyzes the incorporation of one amino acid in the lipopeptide product (Stachelhaus et al. 1995) .
Bacillus spp., especially Bacillus subtilis, Bacillus cereus, and Bacillus amyloliquefaciens, are effective for the control of plant diseases caused by soil-borne, foliar, and postharvest fungal pathogens (Silo-Suh et al. 1994; Raupach and Kloepper 1998; Shoda 2000; Janisiewicz and Korsten 2002; Chiou and Wu 2003; Tjamos et al. 2004) . Fengycin has been shown to exhibit strong antifungal activity in the biocontrol of damping-off of bean seedling caused by Pythium ultimum and gray mold disease of apple caused by Botrytis cineria (Ongena et al. 2005) . Similarly, bacillomycin D exhibits strong antifungal activity towards aflatoxin-producing fungi, such as Aspergillus flavus (Moyne et al. 2001) . Other lipopeptides such as iturin A also exhibit strong antifungal activity and potential for biocontrol (Yoshida et al. 2002; Cho et al. 2003) . Selection and identification of antibiotic-producing bacteria from natural environments through random isolation and screening procedures is time consuming and laborious (de Souza and Raaijmakers 2003) . However, when discovery of strains that produce specific antibiotics is desired, screening candidate strains for particular antibiotic-encoding sequences represents a more expeditious approach.
In this study, bacteria isolated from canola (Brassica napus L.) and wheat (Triticum aestivum L.) that exhibited antifungal activity towards economically important pathogens of canola and wheat were screened using specific polymerase chain reaction (PCR) primers designed to detect the presence of biosynthetic genes of fengycin and bacillomycin D peptide synthetases. Bacillus subtilis 49 (Bs49), which was earlier identified as a fengycin and bacillomycin D producer through ''whole cell'' matrix-assisted laser desorption ionization -time of flight -mass spectroscopy (MALDI-TOF-MS) analysis (Vater et al. 2003) was also included in the PCR screening. This study is unique in that it follows up the PCR detection of the biosynthetic genes of fengycin and bacillomycin D synthetase in strain Bs49 with biochemical extraction, purification, and characterization of the lipopeptides produced. The biochemical analysis serves as a confirmation of the PCR detection, and establishes the prospective use of PCR screening in identifying potential producers of fengycin and bacillomycin D antibiotics.
Materials and methods

Bacterial and fungal cultures and culture conditions
The bacterial identifications and the origin of the 11 Gram-positive bacterial isolates used in this study are presented in Table 1 . Pure cultures of each bacteria were maintained in Luria-Bertani broth, amended with 20% glycerol (Fisher Scientific, Fair Lawn, New Jersey, USA) and stored at -80 8C. Bacterial strains were streaked from the stock onto Luria-Bertani agar or nutrient agar (Difco Laboratories, Detroit, Michigan) plates and incubated at 28 8C for 24 h in an incubator. The fungal cultures of Fusarium graminearum and Sclerotinia sclerotiorum were maintained in potato dextrose agar (PDA; Difco) plates at room temperature under a continuous source of light. Fungal discs from the edge of the colony were used for the inhibition assays. In vitro and in vivo assays for the control of economically important pathogens of canola and wheat The in vitro assays (plate) and in vivo plant assays (greenhouse) for the inhibition of Leptosphaeria maculans (Desm.) Ces (anamorph Phoma lingam (Tode: Fr./Desm.)), the causal agent of Blackleg disease of canola for bacterial strains (DFE3, DFE4, DFE6, DFE11, DFE12, DFE13, DFE15, and DFE16), were done as previously described (Ramarathnam and Fernando 2006) . Similarly, the in vitro assays (plate) and in vivo assays (greenhouse and field) for the inhibition of S. sclerotiorum (Lib.) de Bary, the causal agent of stem rot of canola for bacterial strains (DFE16 and BS6), were done as previously described (Fernando et al. 2007) . Bacillus subtilis B49 isolated from rhizosphere soil of tea exhibited strong inhibition of radial mycelial growth of F. graminearum, Rhizoctonia solani, S. sclerotiorum, Fusarium oxysporum f.sp. vasinfectum, and Botrytis fabae in in vitro plate assays (data not presented).
The ability of B. subtilis DFH08 (DFH08) to inhibit radial mycelial growth of F. graminearum Schwabe (Teleomorph = Gibberella zeae (Schwein.) Petch), the head blight pathogen of wheat, was assayed on PDA and nutrient agar plates and the percent mycelial inhibition was calculated. In greenhouse conditions (25 8C, 14 h photoperiod/day), potential Fusarium head blight antagonistic bacterial strains were individually applied onto the seeds and heads of the highly susceptible cultivar AC-Teal (hard red spring wheat) to investigate the microbial interaction between antagonists and the pathogen in vivo. For seed-coating treatment, germinated seeds were immersed in a bacterial suspension (4.5 Â 10 8 cfu/mL) for 30 min before seeding. When wheat was at 50% flowering, 5 mL of each bacterial suspension was applied to the heads by injecting directly into the floret. The pathogen macroconidia (5 Â 10 5 macroconidia/mL) were inoculated in the same spot either before or after bacterial inoculation. Head inoculation was undertaken as follows: the middle floret of the head was injected with 2 mL of Fusarium macroconidia suspension (5 Â 10 5 macroconidia/mL and 0.04% Tween 80). After inoculation, wheat plants were incubated in a mist chamber for 72 h at 22 8C and transferred to a greenhouse bench. There were 6 treatments (10 pots per replicate and 5 plants in each pot): (i) seed coating with bacteria and bacterial application on head 4 h prior to Fusarium inoculation (BST-BBI), (ii) seed coating with bacteria and bacterial application on head 4 h post Fusarium inoculation (BST-BAI), (iii) seed coating with bacteria and no bacterial application on head (BST) prior to Fusarium application, (iv) bacterial application on head 4 h prior to Fusarium inoculation on head and no seed coating of bacteria (BBI), (v) bacterial application on head 4 h post Fusarium inoculation and no seed coating of bacteria (BAI), and (vi) no seed coating of bacteria and no bacterial application on head prior to Fusarium application (CK). The FHB incidence (the number of heads infected) and severity (the number of diseased spikes on each head) were estimated 16 days after inoculation. Analysis of variance (ANOVA) and a mean separation test (Fisher's Least Significant Difference), at P = 0.05 were performed using the analyst procedure of SAS TM , Version 8.1 (SAS Institute, Cary, North Carolina).
Design of specific primers for the detection of fengycin and bacillomycin D synthetase biosynthetic genes
We designed 2 primer pairs for the detection of the fengycin and bacillomycin D synthetase biosynthetic cluster using the web software Primer3 1 (Rozen and Skaletsky 2000) . A 7.7 kb region (GenBank accession No. AJ011849 (Region: 1-7774) of B. subtilis F29-3) of the fenD gene proposed to be involved in the biosynthesis of 2 modules of fengycin synthetase (Lin et al. 1999 ) was used for the design of the FEND1F and FEND1R specific primer pair. The 2 amino acid activating modules, FenD1 and FenD2, activate L-Tyr and L-Thr, the third and fourth amino acids in fengycin, respectively (Lin et al. 2005) . Similarly, for designing the bacillomycin D specific primer pair, BACC1F and BACC1R, a 7.8 kb region (GenBank accession No. AY137375.1 (Region: 1-7860) of B. subtilis ATTCAU195) involved in the synthesis of bacillomycin D synthetase C was used (Moyne et al. 2004 ). The details of the 2 specific primer pairs are presented in Table 2 . The specificity of the primers were checked with a nucleotide-to-nucleotide BLAST search and also by including unrelated bacterial species in the PCR analysis.
PCR analysis
Total genomic DNA was isolated from bacterial strains by a cetyltrimethylammoniumbromide-based miniprep protocol (Ausubel et al. 1995) . PCR amplifications were performed in a 25 mL reaction mixture containing 20 ng of template DNA; 1Â PCR buffer; 1.75 mmol/L (for BACC1F/ BACC1R) and 2 mmol/L (for FEND1F/FEND1R) MgCl 2 ; 200 mmol/L concentration of each dATP, dCTP, dGTP, and dTTP (Invitrogen, Carlsbad, California); 20 pmol of each primer (Invitrogen); and 0.5 U of Platinum 1 Taq (Invitrogen). PCR amplifications were carried out with a PTC-100 TM programmable thermal controller (MJ Research, Waltham, Massachusetts). The PCR programs used were as follows: (i) BACCIF/BACC1R-initial denaturation at 94 8C for 3 min; 35 cycles of denaturation at 94 8C for 1 min, annealing at 60 8C for 30 s, and extension at 72 8C for 1 min 45 s; and final extension at 72 8C for 6 min; (ii) FEND1F/FEND1R-initial denaturation at 94 8C for 3 min; 45 cycles of denaturation at 94 8C for 1 min, annealing at 62 8C for 1 min, and extension at 72 8C for 1 min 45 s; and final extension at 72 8C for 6 min. Bacillus subtilis ATCC 13952 was used as the positive control for fengycin detection and strain Bs49 was used as the positive control for the bacillomycin D detection. Eight microlitres of each sample was loaded onto a 1% or 1.5% agarose gel containing ethidium bromide and electrophoresed in 1Â Tris-acetate ethylenediamine tetraacetic acid (TAE) buffer at 100-180 V for 1-2 h. The gels were visualized with an ultraviolet illuminator and digitally recorded. The bacterial DNA that tested positive with a specific amplification product were re-amplified with the specific primers and the desired bands were purified with a High Pure TM PCR product purification kit (Roche Diagnostics, Basel, Switzerland). The amplified products were quantified in agarose gel with the 1 kb ladder and were sequenced at MacrogenUSA (Rockville, Maryland). The sequences obtained were searched for homology with sequenced genes in the GenBank database through the National Center for Biotechnology Information Blast search for nucleotides.
Culture of strain Bs49 and preparation of lipopeptides
Bacillus subtilis Bs49 was grown in Landy medium (glucose, 20 g; L-glutamic acid, 5 g; MgSO 4 , 0.5 g; KCl, 0.5 g; KH 2 PO 4 , 1 g; Fe 2 SO 4 Á6H 2 O, 15 mg; MnSO 4 ÁH 2 O, 5.0 mg; and CuSO 4 Á5H 2 O, 0.16 mg; 1000 mL distilled water; final pH 7.0) (Landy et al. 1948) . A loop of strain Bs49 grown on nutrient agar at 32 8C for 24 h was inoculated in 500 mL of Landy medium in a 2 L Erlenmeyer flask, and incubated at 33 8C and 180 r/min for 30 h. Strain Bs49 cells were removed from the cell culture by centrifugation at 4000g for 10-15 min; pH of the supernatant was adjusted to 2.0 by the addition of 6 mol/L HCl and then gently stirred for 2 h or overnight. The precipitate was collected by centrifugation, resuspended in 1 mol/L NaOH to adjust the pH to 7.0, and extracted twice with methanol. The crude lipopeptide was further purified by gel filtration on a 2 cm Â 50 cm Sephadex TM LH-20 column. Finally, the pure lipopeptide was collected and stored at -20 8C.
Preparative separation of strain Bs49 lipopeptides
After precipitation with HCl, the crude lipopeptide fraction dissolved in methanol was evaporated in a rotary evaporator under a vacuum. The dried material was dissolved in a minimum volume of chloroform-methanol (1:1 v/v), applied to a 5 cm Â 150 cm LH-20 column, and fractionated by size exclusion chromatography by using the same solvent for elution. The products were monitored by determining the absorbance at 220 nm.
Analytical scale purification of strain Bs49 lipopeptides
Isolated lipopeptides were purified further and fractionated into isoforms by reversed-phase high-performance liquid chromatography (HPLC) on a mRPC SC 2.1/10 column (Amersham Biosciences, Buckinghamshire, England) at room temperature. A 10-50 mL portion of the lipopeptide fraction was loaded on a mRPC SC 2.1/10 column and separated by high-resolution reversed-phase HPLC by using a Pharmacia Smart TM microseparation system (Amersham Pharmacia Biotech, New Jersey, USA). The products were eluted with a linear gradient of 20%-100% acetonitrile -0.1% trifluoroacetic acid (TFA) in 60 min by using a flow rate of 100 mL/min. Solvent A was 20% acetonitrile in 0.1% TFA (v/v). Solvent B was acetonitrile containing 0.1% TFA (v/v). The eluted biosurfactants were detected by measuring the absorbance at 220 nm. In the fractions obtained, the compounds were detected by MALDI-TOF-MS.
MALDI-TOF-MS analysis of strain Bs49 lipopeptides fractions
Lipopeptides produced by strain Bs49 were characterized through MALDI-TOF-MS, with recording provided by a Bruker TM Reflex instrument (Bruker Daltonics, Billerica, Massachusetts) using a 337 nm nitrogen laser for desorption and ionization. The matrix was a-cyano-4-hydroxycinnamic acid. 
Detection of antifungal activity of strain Bs49 lipopeptides against plant pathogenic fungi
Purified bacillomycin D and fengycin were tested for their antifungal activities by spotting them on sterile filter paper discs placed around the fungal disc located at the centre of PDA plates. Sterile filter paper discs were loaded with 5 mL of the pure lipopeptide suspended in methanol when the radial growth of the fungal mycelium reached 2 cm. The concentration of the lipopeptide suspended in methanol was about 10 mg/mL for fengycin and 20 mg/mL for bacillomycin D. Sterile filter paper discs loaded with methanol were used as the negative control. The results were recorded when the fungal mycelium grew over the control disc.
Results
In vitro and in vivo assays for the control of economically important pathogens of canola and wheat
The results of the in vitro and in vivo assays for the inhibition of L. maculans and S. sclerotiorum are presented in Table 3. Almost all of the endophytic bacteria tested against L. maculans had >50% inhibition of the radial mycelial growth on plates and suppression of disease to levels of resistant ratings on a highly susceptible cultivar (Ramarathnam and Fernando 2006) . Bacterial strains DFE16 and BS6 showed consistent reduction of S. sclerotiorum stem rot in canola (both disease incidence and disease severity) compared with the pathogen control in the greenhouse and field assays (Fernando et al. 2007 ). Strain DFH08 significantly inhibited the radial mycelial growth of F. graminearum on PDA plates by 60% compared with the control (Table 4 ). In plant assays on greenhouse grown wheat at 50% flowering, it was observed that strain DFH08 significantly reduced disease severity in all the 5 treatments when compared with the pathogen control. Seed coating plus application of bacteria on head prior to Fusa- *IP Rating -interaction phenotype (IP) scale of 0-9, where 0 = no darkening around the wounds; 1 = limited blackening around the wound; 3 = dark necrotic lesions; 5 = nonsporulating lesions, sharply limited by dark necrotic margin; 7 = gray-green tissue collapse; and 9 = rapid tissue collapse accompanied by profuse sporulation. Note: BST-BBI, seed coating with bacteria and bacterial application on head 4 h prior to Fusarium inoculation; BST-BAI, seed coating with bacteria and bacterial application on head 4 h post Fusarium inoculation; BST, seed coating with bacteria and no bacterial application on head prior to Fusarium application; BBI, bacterial application on head 4 h prior to Fusarium inoculation on head and no seed coating of bacteria; BAI, bacterial application on head 4 h post Fusarium inoculation and no seed coating of bacteria; CK, no seed coating of bacteria and no bacterial application on head prior to Fusarium application. Treatments followed by the same letter were not significantly different from each other (P = 0.05).
rium inoculation (treatment 1) gave the best disease reduction, even though it was not significantly different from treatment 2 and treatment 4.
PCR analysis
The specificity of the specific primers FEND1F/FEND1R and BACC1F/BACC1R were checked with a nucleotide-tonucleotide BLAST search to see if the primer would hybridize to any other known sequence. The specificity of the primer sequence to its corresponding target sequence in the GenBank and the E-value are presented in Table 5 . Of the 11 bacterial strains tested for the presence of the fenD gene, which is involved in the biosynthesis of FenD1 and FenD2 modules of fengycin synthetase, only isolates DFH08, Bs49, and the positive control (B. subtilis ATCC 13952) produced the 964 bp product (Fig. 1a) . The PCR products of FEND1F/FEND1R were sequenced and analyzed using the National Center for Biotechnology Information nBlast database. The sequences of the PCR products of strains DFH08 and Bs49 showed very high homology to the sequence of the fenD gene of B. subtilis F29-3 (AJ011849) ( Table 6 ). Of the 11 isolates screened with primer pairs BACC1F/BACC1R, only B. cereus DFE4 (DFE4), B. amyloliquefaciens DFE16 (DFE16), B. amyloliquefaciens BS6 (BS6), and the positive control Bs49 yielded the 875 bp product indicative of the presence of the bamC gene of the bacillomycin D biosynthetic cluster (Fig. 1b) . The PCR products derived from primers BACC1F/BACC1R were sequenced and analyzed using the National Center for Biotechnology Information nBlast database. The sequences of the PCR products of strains DFE4, DFE16, BS6, and Bs49 showed very high homology to the sequence of bacillomycin D operon of B. subtilis ATTCAU195 (AY137375) ( Table 6 ). Other Bacillus spp. and Gram positive bacteria included in the analysis did not yield any PCR product, thus establishing the specificity of primer pairs FEND1F/FEND1R and BACC1F/BACC1R.
Chromatography and spectroscopy detection and characterization of strain BS49 lipopeptides
The individual lipopeptide fractions eluted from a mRPC SC 2.1/10 column by high-resolution reversed-phase HPLC using a linear solvent gradient were subjected to MALDI-TOF-MS analysis. Bacillomycin D eluted in HPLC fractions 22-26, while fengycin was detected in fractions 27-33 (Fig.  2) . Peaks in the range of m/z = 1069.5, 1083.7, 1097.6, and 1111.6 were detected in fractions 22-26, which could be attributed to the potassium adducts of C14-C17 bacillomycin D (Fig. 3a) . Chromatographic fractions 27-33 produced peaks in the range of m/z = 1449.8-1543.8, which corresponded to the protonated forms and adducts of C15-C17 fengycins with alkali metal ions (Fig. 3b) .
Detection of antifungal activity of strain Bs49 lipopeptides against plant pathogenic fungi
The lipopeptides fengycin and bacillomycin D isolated from Bs49 culture and loaded onto sterile filter paper discs exhibited a significant inhibitory effect on the radial mycelial growth of F. graminearum and S. sclerotiorum on PDA compared with the control discs. Both fengycin and bacillomycin D exhibited higher agar-diffusible antifungal activity towards S. sclerotiorum (Fig. 4a ) compared with F. graminearum (Fig. 4b) . Fengycin exhibited higher antifungal activity than bacillomycin D, even though the purified lipopeptide suspension of fengycin was half the concentration of the bacillomycin D concentration.
Discussion
To our knowledge this is the first study involving identification of disease-suppressive bacterial antagonists isolated from canola and wheat, which could be potential producers of antifungal lipopeptides such as fengycins and bacillomycin D. This study employed specific PCR primers for the detection of biosynthetic genes of multimodular enzymes, the peptide synthetases, involved in the synthesis of the antifungal lipopeptides fengycin and bacillomycin D. The PCR detection was backed up with the biochemical detection of the compounds, which established the presence of the biosynthetic genes corresponding to the production of the compounds. To our knowledge, this is also the first report of the presence of bacillomycin D biosynthetic genes in a B. cereus strain.
In our earlier studies, we identified bacterial antagonists involved in vitro and in vivo suppression of L. maculans (Ramarathnam and Fernando 2006) and S. sclerotiorum (Fernando et al. 2007 ); these organisms were also included in this study for the PCR analysis. In the present work, we have identified a bacterial antagonist isolated from a wheat head, B. subtilis DFH08, which shows significant suppression of F. graminearum in vitro and in vivo. The competence of a biocontrol agent and synchronization of its activity in time and space with the pathogen are key factors that determine the efficiency of the agent (Folman et al. 2003) . Hence, we considered testing strain DFH08 in vivo Note: S-score is a measure of the similarity of the query to the sequence shown. E-value is a measure of the reliability of the S-score. at the anthesis stage, which is the most crucial stage of head blight infection. It is the infection at anthesis that enables the fusarium fungus to gain access into the head and cause head blight, producing mycotoxins such as deoxynivalenol. If the head can be protected during this narrow window of infection then much of the disease can be controlled. In our study, significant disease control was achieved when the bacteria was applied prior to the inoculation of F. graminearum macroconidia (Table 4 ). The time of application of the bacterial antagonist at the site of infection (on the head) seems to be more crucial than the bacterial seed coating treatment. In this case, no systemic resistance effect was observed with the bacterial seed coating, and it seemed to be more of an antifungal antibiotic effect mediated by strain DFH08 when applied at the site of infection. Agar-diffusible antifungal activity and inhibition of radial mycelial growth is an indication of the potential of a bacterial antagonist to produce antibiotics (Burkhead et al. 1995) . But such in vitro assays and several other screening procedures are time consuming and are not useful in assessing whether a given strain produces a particular antibiotic. Advances in molecular biology have led to the cloning and partial or complete sequencing of antibiotic biosynthetic and regulatory genes, which has facilitated the development of specific primers and probes that can be used for the PCRbased detection of specific antibiotic-producing bacteria (de Souza and Raaijmakers 2003) . This enables processing of environmental bacterial samples in a much quicker and easier manner for the detection of biosynthetic genes involved in antibiotic synthesis. Also, unlike the laborious screening procedures, PCR screening enables precise identification of a particular antibiotic produced by the bacterium since these primers are targeted toward specific antibiotic biosynthetic genes. The primer pairs developed in this study target the biosynthetic genes of the multimodular fengycin and bacillomycin D synthetases. With the help of these primer pairs, strains DFH08 and Bs49 have been identified as potential fengycin producers, and strains DFE4, DFE16, BS6, and Bs49 have been identified as potential bacillomycin D producers. The specificity of the primers is clearly established when the positive data from the PCR was correlated with the purification and characterization of fengycin and bacillomycin D in the purified lipopeptide fraction derived from culture extracts of stain Bs49. This correlation may also exist for the other PCR positive strains to actually synthesize these antifungal lipopeptides. Indeed, this is expected, based on the high antifungal activity and disease suppressive qualities of strains DFE4 (Ramarathnam and Fernando 2006) , DFE16 (Ramarathnam and Fernando 2006; Fernando et al. 2007) , and BS6 (Fernando et al. 2007 ). To our knowledge, this is the first identification of a B. cereus strain (DFE4) positive for the presence of bacillomycin D genes. Strain DFE4 contains biosynthetic genes encoding the aminopolyol antibiotic zwittermicin A (Ramarathnam and Fernando 2006) , thus making it a potential multiple antibiotic producer and likely a strong candidate as a biocontrol agent. Strains DFE4, DFE16, and BS6, isolated from canola phytosphere, with their high disease suppressive and antifungal activities, add further support to the findings of Berg et al. (2002) and Johansson and Wright (2003) , who isolated a high number of disease suppressive, antagonistic bacteria from the Brassicaceae. Other than the presence of the bacillomycin D synthetase gene, strains DFE4, DFE16, and BS6 also test positive for the presence of the ituD gene of the iturin A operon involved in the biosynthesis of the lipopeptide iturin A (data not presented). This potential to produce multiple antibiotics could explain the ability of these bacteria to suppress multiple canola diseases. Also, this opens up avenues to investigate if a synergistic activity of these antibiotics is involved in disease suppression or if it is a single antibiotic effect, and whether it is a means to compete with other microorganisms. The synergistic action of multiple antibiotics enables the members of the sessile actinomycetes to compete with other microorganisms for food and space (Challis and Hopwood 2003) . Bacillus subtilis M4 produces multiple lipopeptides such as surfactins, fengycins, and iturins, but only fengycin was recovered from disease suppressed apple tissue in a study where the bacterium was challenge inoculated with the pathogen (Ongena et al. 2005) . Hence, it is very important to understand the role of different antibiotics in disease control for which mutational studies are required. Single or multiple antibiotic production and activity could be the possible explanation for the antifungal nature of strains DFE4 and DFE16. Both strains exhibit disease suppression when applied at the site of pathogen infection, but no systemic resistance effect in disease reduction when applied away from the pathogen (data not presented). Similar results were obtained in this study for strain DFH08, a potential fengycin producer, where reduction in disease severity of Fusarium   Fig. 4 . Inhibition of radial mycelial growth of Sclerotinia sclerotiorum (a) and Fusarium graminearum (b) by purified fengycin and bacillomycin D. Five microlitres of the purified lipopeptide was loaded onto sterile filter paper discs. The plates were scored when the mycelium grew over the control discs.
head blight was seen when the bacterium was challenge inoculated with the pathogen on the wheat head, and no disease reduction or systemic resistance effect observed when applied as a seed treatment. These findings could be further strengthened by the isolation of the antibiotics from the site of infection.
From an environmental point of view, understanding the different mechanisms such as direct antagonism or induced systemic resistance employed by these potential biocontrol bacteria would give us more options to consider and integrate them into a disease management program involving minimal use of hazardous synthetic fungicides. Also, because many of these metabolites exhibit various biologically active ingredients, they are useful targets for biotechnological and biopharmaceutical interest (Vater et al. 2003) . The antifungal activities of fengycin (Ongena et al. 2005 ) and bacillomycin D (Moyne et al. 2001 ), antiviral and antimicrobial activity of surfactins (Peypoux et al. 1999) , and strong antifungal, hemolytic, and limited antibacterial activities of the iturins (Maget-Dana and Peypoux 1994) are few good examples. The natural pools of these lipopeptides can be extended in a directed manner by biocombinatoric efforts involving recombinant peptide synthetases, which synthesize these lipopeptides nonribosomally (Vater et al. 2003) . Recombinant peptide synthetases can be obtained by swapping their module and domain, and also by site-specific mutagenesis of the amino acid residues involved in the intermediate steps of peptide synthesis. The Bacillus species, which are natural producers of these lipopeptides, could act as a rich genetic source for the construction of large biocombinatorial libraries of genetically engineered peptide synthetases for novel peptide design.
